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Interaction of eIF4G with poly(A)-binding protein stimulates
translation and is critical for Xenopus oocyte maturation
Motoaki Wakiyama, Hiroaki Imataka and Nahum Sonenberg
The poly(A)-binding protein Pab1p interacts directly with
the eukaryotic translation initiation factor 4G (eIF4G) to
facilitate translation initiation of polyadenylated mRNAs
in yeast [1,2]. Although the eIF4G–PABP interaction has
also been demonstrated in a mammalian system [3,4], its
biological significance in vertebrates is unknown. In
Xenopus oocytes, cytoplasmic polyadenylation of several
mRNAs coincides with their translational activation and
is critical for maturation [5–7]. Because the amount of
PABP is very low in oocytes [8], it has been argued that
the eIF4G–PABP interaction does not play a major role in
translational activation during oocyte maturation. Also,
overexpression of PABP in Xenopus oocytes has only a
modest stimulatory effect on translation of
polyadenylated mRNA and does not alter either the
efficiency or the kinetics of progesterone-induced
maturation [9]. Here, we report that the expression of an
eIF4GI mutant defective in PABP binding in Xenopus
oocytes reduces translation of polyadenylated mRNA
and dramatically inhibits progesterone-induced
maturation. Our results show that the eIF4G–PABP
interaction is critical for translational control of maternal
mRNAs during Xenopus development. 
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Results and discussion
As Xenopus eIF4G has not been cloned, we used a human
eIF4GI cDNA [3] in our studies. Furthermore, the
amino-acid sequence of the eIF4G-binding region in PABP
is highly conserved between human and Xenopus. The
PABP-binding region in eIF4GI spans amino acids
132–160 (Figure 1a). Previously, we generated an eIF4GI
mutant by converting the amino acids 134KRERK138 in
the PABP-binding region to alanines (Figure 1a). This
mutation reduces the PABP-binding activity of eIF4GI
significantly but not completely [3]. When an additional
four amino acids (144DPNQ147) were changed to alanines
(Figure 1a), binding of eIF4GI to PABP was abrogated in
Xenopus oocytes (Figure 1d) and in HeLa cells (data not
shown). To facilitate the detection of human eIF4GI in
Xenopus oocyte, the FLAG epitope sequence was fused to
Figure 1
Expression of human eIF4GI in Xenopus oocytes. (a) Schematic
diagram of human wild-type and mutant eIF4GI proteins. The binding
sites for PABP, eIF4E, eIF3 and eIF4A are indicated. The amino-acid
sequence of the PABP-binding site is shown below. Amino-acid
residues that were changed to alanines in the mutant protein are
underlined. (b) Uninjected oocytes (control), or oocytes injected with
50 ng mRNA encoding eIF4GIwt or eIF4GImut were metabolically
labeled with [35S]methionine at 1 mCi/ml for 20 h. Total proteins
extracted from the oocytes were resolved by SDS–PAGE and
visualized by autoradiography. Each lane contains proteins equivalent
to 0.2 oocytes. (c) Western blot analysis. Each lane contains protein
equivalent to 0.4 oocytes. Rabbit anti-eIF4GI antibody was prepared
against a glutathione-S-transferase (GST)–eIF4GI (amino acids
132–160) fusion protein, which was bacterially expressed.
(d) Co-immunoprecipitation of expressed eIF4GI with associated
proteins using anti-FLAG antibody. Oocytes were injected with 30 ng
mRNA encoding eIF4GIwt or eIF4GImut. Each lane contains protein
from 10 oocytes. The anti-PABP and anti-eIF4A antibodies were
described previously [3,15]. (e) Interaction of eIF4GI with eIF4E.
Oocytes were injected with 30 ng eIF4GIwt or eIF4GImut mRNA and
5 ng HA-tagged eIF4E mRNA [15], and the co-immunoprecipitation
experiment was performed as described in (d).
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the carboxyl terminus of the protein [10]. We injected
mRNAs encoding wild-type or mutant eIF4GI (eIF4GIwt
or eIF4GImut, respectively) into stage VI oocytes. Both
proteins were synthesized to similar levels, as determined
by [35S]methionine incorporation and western analysis
(Figure 1b,c). Two different antibodies were used to
detect eIF4GI. An antibody against the PABP-binding
region (amino acids 132–160) in human eIF4GI recog-
nized both human eIF4GI and endogenous Xenopus
eIF4G (Figure 1c, upper panel). As the amino-acid
sequence in the PABP-binding region in human eIF4GI
and eIF4GII are conserved [3], the putative Xenopus
eIF4GI and eIF4GII should also be detected with the
same antibody. Human eIF4GI (arrow) migrated faster
than endogenous eIF4G. The antibody recognized
eIF4GImut, although weakly compared with the wild-
type protein. The antibody probably recognized the
portion of the PABP-binding region that was not mutated.
The expressed eIF4GI was also detected using anti-
FLAG antibody (Figure 1c, lower panel). 
To determine whether human eIF4GI functions in
oocytes, the interaction between eIF4GI and endogenous
PABP was first examined. Extracts were prepared from
oocytes injected with eIF4GIwt or eIF4GImut mRNAs,
followed by immunoprecipitation of the expressed eIF4GIs
using anti-FLAG antibody. As a control for eIF4GI
function, which is not expected to be affected by the
mutation, we examined eIF4A and eIF4E binding. Both
eIF4GIwt and eIF4GImut interacted with endogenous
eIF4A to the same extent, as detected by western analysis
(Figure 1d). In contrast, endogenous PABP associated
with eIF4GIwt but not with eIF4GImut (Figure 1d).
These results demonstrate that human eIF4GI binds to
Xenopus PABP, and mutations in the PABP-binding region
abolish this interaction. The interaction of eIF4GI with
eIF4E was also examined by injecting eIF4GI mRNA
together with mRNA encoding hemagglutinin epitope
(HA)-tagged eIF4E into oocytes (HA-tagged eIF4E was
used because endogenous eIF4E comigrates with the
immunoglobulin light chain). A co-immunoprecipitation
experiment demonstrated that the mutation in the PABP-
binding region did not alter the interaction of eIF4GI with
eIF4E (Figure 1e). 
To examine the effect of eIF4GIwt and eIF4GImut on
translation of polyadenylated versus non-adenylated
mRNAs, a translation assay with a luciferase reporter
mRNA was performed. A capped luciferase mRNA con-
taining either a 98-nucleotide poly(A) tail (A98) or lacking
a poly(A) tail (A0) was used. Oocytes were injected with
eIF4GI mRNAs and incubated for 18–20 hours, followed
by injection with luciferase mRNA and incubation for an
additional 4 hours (see Supplementary material). The
poly(A) tail stimulated luciferase synthesis both in
oocytes expressing eIF4GIwt and in control oocytes that
were not injected with eIF4GIwt mRNA (~10-fold and
~25-fold, respectively ; Figure 2a, compare sample groups
1,4, and 3,6; three experiments were done with A98
mRNA and two with A0 mRNA). Expression of
eIF4GIwt had no significant effect on translation of A98
mRNA (Figure 2a, compare 1,3). In contrast, the expres-
sion of eIF4GImut decreased translation of A98 mRNA
(36–57% of that in oocytes expressing eIF4GIwt, compare
sample groups 1,2; because the effect of eIF4GImut on
translation of A98 mRNA is dependent on the amount of
expressed eIF4GImut compared with endogenous eIF4G,
the expression of eIF4GImut might not be sufficient to
abrogate the effect of the poly(A) tail). There was no sig-
nificant difference in expression levels of eIF4GIwt and
eIF4GImut in this experiment (data not shown). Signifi-
cantly, neither eIF4GIwt nor eIF4GImut decreased trans-
lation of A0 mRNA (compare sample groups 4–6), which
indicates that the mutation in the PABP-binding region
did not affect the interaction of eIF4GI with other initia-
tion factors. Expression of eIF4GIwt or eIF4GImut mod-
estly stimulated translation of A0 mRNA. RNA analysis
demonstrated that all mRNAs exhibited similar stability
(see Supplementary material), indicating that the differ-
ence in luciferase activity reflects changes in translation.
These results demonstrate that eIF4GImut inhibits
poly(A)-dependent translation in Xenopus oocytes, most
probably by acting as a dominant-negative inhibitor. 
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Figure 2
The eIF4GI mutant inhibits translation of polyadenylated, but not non-
adenylated mRNAs. For the luciferase assay, luminescence was
measured and normalized by quantifying the radioactivity of
32P-labeled luciferase mRNA. One to two pools of five oocytes were
collected for each sample. Values are relative to those obtained with
oocytes injected with eIF4GIwt and A98 mRNAs, which were set at
100 (sample group 1). The amount of mRNA injected into each oocyte
was: eIF4GIwt or eIF4GImut, 60 ng for the experiment represented by
the dark grey bars or 30 ng for the other two experiments; luciferase
(A0 or A98), 0.3–0.4 ng (~2,000 cpm).
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Progesterone-induced Xenopus oocyte maturation can be
assessed by the appearance of a characteristic white spot at
the animal pole, indicating germinal vesicle breakdown
(GVBD). As poly(A)-tail elongation of certain mRNAs is
necessary for activation of translation and concomitant
oocyte maturation [5,6], our results predict that expression
of eIF4GImut should result in inhibition of oocyte matura-
tion. To test this prediction, oocytes expressing eIF4GIwt
or eIF4GImut were incubated for 8–23 hours in the pres-
ence of progesterone. Strikingly, the expression of
eIF4GImut dramatically inhibited maturation (a represen-
tative result is shown in Figure 3a). Only 10% of the oocytes
expressing eIF4GImut underwent GVBD, whereas about
70% of the oocytes expressing eIF4GIwt and 80% of
control oocytes underwent GVBD after 23 hours of incuba-
tion with progesterone. Expression of eIF4GIwt had no
effect on the kinetics of maturation. The eIF4GImut
effect was specific, inasmuch as co-expression of eIF4GIwt
with eIF4GImut (w + m) strongly mitigated the inhibitory
effect of eIF4GImut. As a control, injection of twice the
amount of eIF4GIwt (2 × wt) had no effect on maturation.
The accumulation of c-Mos protein, which is necessary for
progesterone-induced maturation [11] in oocytes that have
undergone GVBD was confirmed by western blot analysis
(Figure 3b). These results strongly support the idea that
the interaction between eIF4G and PABP is necessary for
translational activation of mRNAs encoding proteins
required for oocyte maturation.
Certain maternal mRNAs are polyadenylated in the cyto-
plasm, and translationally activated concomitant with
oocyte maturation. These mRNAs have two distinct signals
in their 3′ untranslated regions (UTRs): an AAUAAA
sequence, which is a highly conserved nuclear polyadenyla-
tion sequence, and a U-rich sequence termed the cytoplas-
mic polyadenylation element (CPE) [5,6]. Translational
regulation of c-mos mRNA is an established key regulatory
step in Xenopus oocyte maturation [11–13]; c-mos mRNA
possesses a CPE in its 3′ UTR and is polyadenylated during
oocyte maturation [12]. Cytoplasmic polyadenylation is crit-
ical for c-mos mRNA translation. Indeed, a luciferase
reporter mRNA containing the c-mos CPE (Luc/c-mos) is
polyadenylated, and its translation is stimulated in Xenopus
oocytes in response to progesterone treatment [12]. 
To show that the eIF4G–PABP interaction is important
for c-mos translational activation and, consequently, oocyte
maturation, we examined the effect of eIF4GImut on the
translation of Luc/c-mos mRNA in oocytes. Control
oocytes and oocytes expressing eIF4GIwt or eIF4GImut
were injected with Luc/c-mos mRNA and incubated in the
presence or absence of progesterone for 5–7 hours (see
Supplementary material). Progesterone stimulated transla-
tion in control oocytes (~4.5-fold; Figure 4, compare
bars 1,2), and in eIF4GIwt-expressing oocytes (twofold;
Figure 4, compare bars 3,4). In contrast, the stimulation in
eIF4GImut-expressing oocytes was negligible (Figure 4,
compare bars 5,6). The synthesis of luciferase in
eIF4GImut-expressing oocytes in the absence of proges-
terone was about twofold higher than in control oocytes.
The reason for this difference is not immediately clear. All
luciferase mRNAs exhibited similar stability as deter-
mined by gel electrophoresis (data not shown; the possi-
bility, however, that eIF4GImut affects poly(A) tail
elongation could not be ruled out from this experiment).
The percentage of oocytes that had undergone GVBD was
greater than 85% for control oocytes and oocytes express-
ing eIF4GIwt, whereas it was less than 10% for oocytes
expressing eIF4GImut. These results strongly suggest
that eIF4GImut, which is defective in PABP binding,
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Figure 3
Expression of the eIF4GI mutant inhibits progesterone-induced
maturation. (a) Maturation was induced by incubating oocytes in OR2
medium containing 10 µg/ml progesterone. The percentage of GVBD
in each group of oocytes was determined by the appearance of a
white spot on the oocyte animal pole. The amount of mRNA injected
into each oocyte and the number of oocytes in each group were:
control (23 oocytes); wild type (26 oocytes), 30 ng eIF4GIwt; mutant
(23 oocytes), 30 ng eIF4GImut; w + m (25 oocytes), 30 ng eIF4GIwt
plus 30 ng eIF4GImut; 2 × wt (24 oocytes), 60 ng eIF4GIwt. The
experiment for control, wild type and mutant was repeated five times,
twice each for w + m and 2 × wt, and similar results were obtained.
(b) Western blot analysis of c-Mos protein. Oocytes were taken after
9.5 h of incubation with progesterone. For the control, wild type, w + m
and 2 × wt, lysate was prepared only from oocytes that had undergone
GVBD. For the mutant, lysate was prepared from oocytes that had not
undergone GVBD. Approximately one oocyte equivalent of proteins
was resolved by SDS–PAGE and subjected to western blotting with
anti-c-Mosxe antibody (C237, Santa Cruz Biotechnology).
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prevents progesterone-induced maturation as a conse-
quence of its inhibition of translational activation. 
The requirement for intact eIF4G in Xenopus oocyte mat-
uration has been addressed previously [14]. The authors
used Coxsackievirus protease 2A to cleave eIF4G in
Xenopus oocytes, causing inhibition of Mos expression and
progesterone-induced maturation. They also showed that
the expression of a non-cleavable form of eIF4G restored
Mos-expression. However, while protease 2A cleaves off
the amino-terminal portion of eIF4G containing the
PABP-binding region, the eIF4G used to restore transla-
tion lacked the amino-terminal 156 amino acids, which
contains the PABP-binding site [3]. Thus, the restoration
of translation by eIF4G in [14] cannot be explained by
restoration of the PABP–eIF4G interaction, and therefore
the underlying reason for the phenomenon is different
from that described in our paper. 
Supplementary material
Supplementary material including additional discussion and methodologi-
cal detail is available at http://current-biology.com/supmat/supmatin.htm.
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Figure 4
The eIF4GI mutant inhibits maturation-specific translational activation
of Luc/c-mos mRNA. Each oocyte was injected with 30 ng eIF4GIwt
or eIF4GImut mRNA and 0.4–0.5 ng (~2,000 cpm) Luc/c-mos mRNA.
–P and +P denote the absence and the presence of progesterone,
respectively. The graph shows the measurement of luciferase activity
generated from injected Luc/c-mos mRNA. Values are relative to that
obtained with control oocytes incubated in the absence of
progesterone, which was set at 100 (bar 1). Eight oocytes were
collected and assayed. Luciferase activity was normalized by
quantifying the radioactivity of 32P-labeled Luc/c-mos mRNA in each
sample. The bars depict the mean with standard error from three
independent experiments. For bars 2 and 4, lysate was prepared only
from oocytes that had undergone GVBD. For bar 6, lysate was
prepared from oocytes that had not undergone GVBD. The percentage
of GVBD in each group is indicated below the figure. The ratio of
luciferase activity observed in mature versus immature oocytes (+P/–P,
maximum and minimum from three independent experiments) is also
indicated. For each sample, 16–21 oocytes were injected, using
oocytes from different frogs for each experiment.
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